Scanogen, Inc.
Scanogen is a molecular diagnostic company focused on developing rapid and ultra-sensitive detection systems for biomolecules in body fluids. Utilizing their proprietary Single MOLecule Tethering (SMOLT) technology, Scanogen aims to improve healthcare by providing quick and actionable diagnostic results, particularly in the areas of bloodstream and respiratory infections.
Industries
Nr. of Employees
small (1-50)
Scanogen, Inc.
Patents
Products
Amplification-free single-molecule tethering diagnostic platform (sample-to-answer)
A diagnostic platform that uses long-probe tethering and bead displacement measured by optical imaging to detect nucleic acids and microorganisms without amplification, intended as a sample-to-answer system for clinical samples.
Point-of-care bloodstream pathogen identification assay (sepsis application)
A rapid assay design for direct identification of bloodstream pathogens without blood culture, reported sensitivity down to 1 CFU/mL and intended turnaround ~60 minutes; under development for point-of-care use.
Saliva-based viral RNA detection assay (research prototype)
Adaptation of the amplification-free tethering detection method for direct detection of viral genomes in saliva; reported limit of detection ~150 copies per 30 µL.
Amplification-free single-molecule tethering diagnostic platform (sample-to-answer)
A diagnostic platform that uses long-probe tethering and bead displacement measured by optical imaging to detect nucleic acids and microorganisms without amplification, intended as a sample-to-answer system for clinical samples.
Point-of-care bloodstream pathogen identification assay (sepsis application)
A rapid assay design for direct identification of bloodstream pathogens without blood culture, reported sensitivity down to 1 CFU/mL and intended turnaround ~60 minutes; under development for point-of-care use.
Saliva-based viral RNA detection assay (research prototype)
Adaptation of the amplification-free tethering detection method for direct detection of viral genomes in saliva; reported limit of detection ~150 copies per 30 µL.
Services
Collaborative development of diagnostic assays for bloodstream and respiratory infections, including optimization for direct detection in clinical samples and rapid sample-to-answer workflows.
Collaborative development of diagnostic assays for bloodstream and respiratory infections, including optimization for direct detection in clinical samples and rapid sample-to-answer workflows.
Expertise Areas
- Amplification-free molecular diagnostics
- Single-molecule detection methods
- Point-of-care and point-of-need diagnostic development
- Bloodstream pathogen (sepsis) diagnostics
Key Technologies
- Single-molecule tethering detection
- Bead displacement / particle tracking
- Large field-of-view optical imaging
- Long polymer probe tethers (DNA-based probes)
News & Updates
Granted for a novel method to eliminate background noise in assays based on a solid substrate.
Covers the optical system used in SMOLT, including an imaging system to determine the position or movement of particles over a large field of view.
Covers Single Molecule Tethering (SMOLT) technology, including detection of molecules using long probes.
Granted for a novel method to eliminate background noise in assays based on a solid substrate.
Covers the optical system used in SMOLT, including an imaging system to determine the position or movement of particles over a large field of view.
Covers Single Molecule Tethering (SMOLT) technology, including detection of molecules using long probes.